{"id":241020,"date":"2025-08-05T23:29:31","date_gmt":"2025-08-05T21:29:31","guid":{"rendered":"https:\/\/fefac.cat\/empresarial\/?p=241020"},"modified":"2025-08-06T00:00:10","modified_gmt":"2025-08-05T22:00:10","slug":"comunicat-oficial-fefac-cas-ima-contigo","status":"publish","type":"post","link":"https:\/\/fefac.cat\/empresarial\/comunicat-oficial-fefac-cas-ima-contigo\/","title":{"rendered":"Comunicat oficial de la FEFAC sobre el cas IMA Health"},"content":{"rendered":"\n<p>Davant les informacions publicades recentment en diversos mitjans de comunicaci\u00f3, i en particular, l\u2019article de <em>La Vanguardia<\/em> titulat \u201cIMA Health contra el Goliat farmac\u00e8utic\u201d (4 d\u2019agost de 2025), la Federaci\u00f3 d\u2019Associacions de Farm\u00e0cies de Catalunya (FEFAC) vol fer les seg\u00fcents manifestacions.<\/p>\n\n\n\n<p>Segons l\u2019article esmentat, l\u2019Audi\u00e8ncia Nacional ha dictat una sent\u00e8ncia favorable a la <em>startup<\/em> catalana IMA Health, reconeixent la legalitat del seu model de lliurament de medicaments a domicili, sempre que el pacient ho consenteixi mitjan\u00e7ant autoritzaci\u00f3 expressa.<\/p>\n\n\n\n<p>L\u2019article tamb\u00e9 afirma que aquesta resoluci\u00f3 judicial posa fi a una \u201cbatalla\u201d entre l\u2019empresa i l\u2019Ag\u00e8ncia Espanyola de Medicaments i Productes Sanitaris (AEMPS), FEFAC i diversos col\u00b7legis professionals, i inclou afirmacions que apunten que IMA Health hauria rebut \u201camenaces per carta\u201d de l\u2019AEMPS i de la FEFAC en relaci\u00f3 amb la seva activitat.<\/p>\n\n\n\n<p>Davant d\u2019aquestes informacions, i a l\u2019espera de poder accedir al text complet de la Sent\u00e8ncia, des de la FEFAC volem efectuar els seg\u00fcents aclariments. &nbsp;<\/p>\n\n\n\n<p>La FEFAC no ha estat part en cap procediment judicial contenci\u00f3s-administratiu relacionat amb IMA Health. No hem estat condemnats, ni parts interessades, ni hem intervingut en el proc\u00e9s judicial resolt per l\u2019Audi\u00e8ncia Nacional al que es refereix la not\u00edcia.<\/p>\n\n\n\n<p>L\u2019\u00fanica actuaci\u00f3 de la FEFAC es va limitar a comunicar formalment, pels canals legals establerts, a l\u2019autoritat competent de Catalunya, al Departament de Salut de la Generalitat de Catalunya, l\u2019exist\u00e8ncia d\u2019una pr\u00e0ctica que, al nostre entendre, podia vulnerar la normativa vigent sobre la dispensaci\u00f3 de medicaments.<\/p>\n\n\n\n<p>Posteriorment,&nbsp;va ser l\u2019AEMPS qui, actuant dins del seu \u00e0mbit competencial, va iniciar un procediment administratiu contra IMA Health que culmin\u00e0 amb la Resoluci\u00f3 de 24 d\u2019octubre de 2022 per la que es requeria la interrupci\u00f3\/i o retirada del servei consistent en la venda&nbsp;a dist\u00e0ncia de medicaments a trav\u00e9s del lloc web de l\u2019empresa i la seva aplicaci\u00f3 per a dispositius m\u00f2bils, a l&#8217;estimar-se que aquest servei suposava una activitat il\u00b7legal d\u2019intermediaci\u00f3 en la venda a dist\u00e0ncia de medicaments.<\/p>\n\n\n\n<p>En qualsevol cas, l\u2019actuaci\u00f3 de la FEFAC es va fer amb l\u2019objectiu de defensar la legalitat, garantir la seguretat dels pacients i preservar el model assistencial de farm\u00e0cia comunit\u00e0ria, que entenem pilar del nostre sistema sanitari.<\/p>\n\n\n\n<p>En aquest sentit, rebutgem rotundament que es qualifiqui d\u2019amena\u00e7a l\u2019actuaci\u00f3 legal i leg\u00edtima de la FEFAC. Utilitzar aquest tipus d\u2019expressions desvirtua els fets, desqualifica injustament la funci\u00f3 representativa de la nostra entitat i genera un relat distorsionat que no s\u2019ajusta a la realitat.<\/p>\n\n\n\n<p>La FEFAC sempre ha defensat i seguir\u00e0 defensant la innovaci\u00f3 en l\u2019\u00e0mbit de la salut i la incorporaci\u00f3 de noves tecnologies, sempre que aquestes es desenvolupin dins del marc legal i amb ple respecte per la normativa sanit\u00e0ria i farmac\u00e8utica vigent. Qualsevol model que afecti a la dispensaci\u00f3 de medicaments ha de garantir la seguretat sanit\u00e0ria, la tra\u00e7abilitat i la responsabilitat professional.<\/p>\n\n\n\n<p>Des de FEFAC, continuarem treballant per defensar la tasca essencial de les farm\u00e0cies comunit\u00e0ries, com a establiments sanitaris regulats, pr\u00f2xims, accessibles i garants d\u2019una atenci\u00f3 farmac\u00e8utica segura, efica\u00e7 i de qualitat per a tota la ciutadania.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>Not\u00edcies relacionades<\/strong><\/h3>\n\n\n\n<p>11.11.2022. <strong><em><span style=\"text-decoration: underline\"><a href=\"https:\/\/fefac.cat\/empresarial\/tv3-rac1-cessament-publi-ima-contigo\/\" target=\"_blank\" rel=\"noreferrer noopener\">El CAC requereix a TV3 i a RAC 1 que cessin la publicitat de l&#8217;empresa IMA Contigo<\/a><\/span><\/em><\/strong><br>04.11.2022. <strong><em><span style=\"text-decoration: underline\"><a href=\"https:\/\/fefac.cat\/empresarial\/ima-contigo-carta-dep-salut-fefac\/\" target=\"_blank\" rel=\"noreferrer noopener\">L\u2019activitat d\u2019IMA Contigo suposa una activitat il\u00b7legal de venda a dist\u00e0ncia de medicaments, segons l\u2019Aemps<\/a><\/span><\/em><\/strong><br>04.11.2022.<strong><em><span style=\"text-decoration: underline\"><a href=\"https:\/\/fefac.cat\/empresarial\/informacio-salut-servei-ima-contigo\/\" target=\"_blank\" rel=\"noreferrer noopener\"> Informacio d\u2019\u00faltima hora sobre el servei IMA Contigo<\/a><\/span><\/em><\/strong><br>22.04.2022. <strong><em><span style=\"text-decoration: underline\"><a href=\"https:\/\/fefac.cat\/empresarial\/consultes-servei-ima-contigo\/\" target=\"_blank\" rel=\"noreferrer noopener\">Consultes sobre el Servei IMA Contigo<\/a><\/span><\/em><\/strong><br><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Davant les informacions publicades recentment en diversos mitjans de comunicaci\u00f3, i en particular, l\u2019article de La Vanguardia titulat \u201cIMA Health contra el Goliat farmac\u00e8utic\u201d (4 d\u2019agost de 2025), la Federaci\u00f3 d\u2019Associacions de Farm\u00e0cies de Catalunya (FEFAC) vol fer les seg\u00fcents manifestacions.<\/p>\n","protected":false},"author":2313,"featured_media":224377,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"off","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[2066,2067,10,11,12,13,14,15,297,251],"tags":[387,2485],"class_list":["post-241020","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-categoria-actualitat","category-notes-premsa","category-empresarials","category-fefac","category-afb","category-afet","category-afell","category-agfe","category-fefac-actua","category-reflexions-de-junta","tag-departament-de-salut","tag-ima-contigo"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Comunicat oficial de la FEFAC sobre el cas IMA Health - FEFAC<\/title>\n<meta name=\"description\" content=\"Davant les informacions publicades recentment en diversos mitjans de comunicaci\u00f3, i en particular, l\u2019article de La Vanguardia titulat \u201cIMA Health contra el Goliat farmac\u00e8utic\u201d (4 d\u2019agost de 2025), la Federaci\u00f3 d\u2019Associacions de Farm\u00e0cies de Catalunya (FEFAC) vol fer les seg\u00fcents manifestacions.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/fefac.cat\/empresarial\/comunicat-oficial-fefac-cas-ima-contigo\/\" \/>\n<meta property=\"og:locale\" content=\"ca_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Comunicat oficial de la FEFAC sobre el cas IMA Health - FEFAC\" \/>\n<meta property=\"og:description\" content=\"Davant les informacions publicades recentment en diversos mitjans de comunicaci\u00f3, i en particular, l\u2019article de La Vanguardia titulat \u201cIMA Health contra el Goliat farmac\u00e8utic\u201d (4 d\u2019agost de 2025), la Federaci\u00f3 d\u2019Associacions de Farm\u00e0cies de Catalunya (FEFAC) vol fer les seg\u00fcents manifestacions.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/fefac.cat\/empresarial\/comunicat-oficial-fefac-cas-ima-contigo\/\" \/>\n<meta property=\"og:site_name\" content=\"FEFAC\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-05T21:29:31+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-08-05T22:00:10+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/fefac.cat\/empresarial\/wp-content\/uploads\/2020\/06\/logo-fefac-notis.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"230\" \/>\n\t<meta property=\"og:image:height\" content=\"160\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"lclavijo@afb.cat\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrit per\" \/>\n\t<meta name=\"twitter:data1\" content=\"lclavijo@afb.cat\" \/>\n\t<meta name=\"twitter:label2\" content=\"Temps estimat de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minuts\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/comunicat-oficial-fefac-cas-ima-contigo\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/comunicat-oficial-fefac-cas-ima-contigo\\\/\"},\"author\":{\"name\":\"lclavijo@afb.cat\",\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/#\\\/schema\\\/person\\\/6ac15c94fb359972b6bfa9c752486744\"},\"headline\":\"Comunicat oficial de la FEFAC sobre el cas IMA Health\",\"datePublished\":\"2025-08-05T21:29:31+00:00\",\"dateModified\":\"2025-08-05T22:00:10+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/comunicat-oficial-fefac-cas-ima-contigo\\\/\"},\"wordCount\":624,\"commentCount\":4,\"image\":{\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/comunicat-oficial-fefac-cas-ima-contigo\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/wp-content\\\/uploads\\\/2020\\\/06\\\/logo-fefac-notis.jpg\",\"keywords\":[\"Departament de Salut\",\"IMA Contigo\"],\"articleSection\":[\"Actualitat\",\"Notes de premsa\",\"Empresarials\",\"FEFAC\",\"AFB\",\"AFET\",\"AFELL\",\"AGFE\",\"FEFAC Actua\",\"Reflexions de Junta\"],\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/comunicat-oficial-fefac-cas-ima-contigo\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/comunicat-oficial-fefac-cas-ima-contigo\\\/\",\"url\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/comunicat-oficial-fefac-cas-ima-contigo\\\/\",\"name\":\"Comunicat oficial de la FEFAC sobre el cas IMA Health - FEFAC\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/comunicat-oficial-fefac-cas-ima-contigo\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/comunicat-oficial-fefac-cas-ima-contigo\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/wp-content\\\/uploads\\\/2020\\\/06\\\/logo-fefac-notis.jpg\",\"datePublished\":\"2025-08-05T21:29:31+00:00\",\"dateModified\":\"2025-08-05T22:00:10+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/#\\\/schema\\\/person\\\/6ac15c94fb359972b6bfa9c752486744\"},\"description\":\"Davant les informacions publicades recentment en diversos mitjans de comunicaci\u00f3, i en particular, l\u2019article de La Vanguardia titulat \u201cIMA Health contra el Goliat farmac\u00e8utic\u201d (4 d\u2019agost de 2025), la Federaci\u00f3 d\u2019Associacions de Farm\u00e0cies de Catalunya (FEFAC) vol fer les seg\u00fcents manifestacions.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/comunicat-oficial-fefac-cas-ima-contigo\\\/#breadcrumb\"},\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/comunicat-oficial-fefac-cas-ima-contigo\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/comunicat-oficial-fefac-cas-ima-contigo\\\/#primaryimage\",\"url\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/wp-content\\\/uploads\\\/2020\\\/06\\\/logo-fefac-notis.jpg\",\"contentUrl\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/wp-content\\\/uploads\\\/2020\\\/06\\\/logo-fefac-notis.jpg\",\"width\":230,\"height\":160},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/comunicat-oficial-fefac-cas-ima-contigo\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Comunicat oficial de la FEFAC sobre el cas IMA Health\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/#website\",\"url\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/\",\"name\":\"FEFAC\",\"description\":\"Federaci\u00f3 d&#039;Associacions de Farm\u00e0cies de Catalunya\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ca\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/#\\\/schema\\\/person\\\/6ac15c94fb359972b6bfa9c752486744\",\"name\":\"lclavijo@afb.cat\",\"url\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/author\\\/laura-2\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Comunicat oficial de la FEFAC sobre el cas IMA Health - FEFAC","description":"Davant les informacions publicades recentment en diversos mitjans de comunicaci\u00f3, i en particular, l\u2019article de La Vanguardia titulat \u201cIMA Health contra el Goliat farmac\u00e8utic\u201d (4 d\u2019agost de 2025), la Federaci\u00f3 d\u2019Associacions de Farm\u00e0cies de Catalunya (FEFAC) vol fer les seg\u00fcents manifestacions.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/fefac.cat\/empresarial\/comunicat-oficial-fefac-cas-ima-contigo\/","og_locale":"ca_ES","og_type":"article","og_title":"Comunicat oficial de la FEFAC sobre el cas IMA Health - FEFAC","og_description":"Davant les informacions publicades recentment en diversos mitjans de comunicaci\u00f3, i en particular, l\u2019article de La Vanguardia titulat \u201cIMA Health contra el Goliat farmac\u00e8utic\u201d (4 d\u2019agost de 2025), la Federaci\u00f3 d\u2019Associacions de Farm\u00e0cies de Catalunya (FEFAC) vol fer les seg\u00fcents manifestacions.","og_url":"https:\/\/fefac.cat\/empresarial\/comunicat-oficial-fefac-cas-ima-contigo\/","og_site_name":"FEFAC","article_published_time":"2025-08-05T21:29:31+00:00","article_modified_time":"2025-08-05T22:00:10+00:00","og_image":[{"width":230,"height":160,"url":"https:\/\/fefac.cat\/empresarial\/wp-content\/uploads\/2020\/06\/logo-fefac-notis.jpg","type":"image\/jpeg"}],"author":"lclavijo@afb.cat","twitter_card":"summary_large_image","twitter_misc":{"Escrit per":"lclavijo@afb.cat","Temps estimat de lectura":"4 minuts"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/fefac.cat\/empresarial\/comunicat-oficial-fefac-cas-ima-contigo\/#article","isPartOf":{"@id":"https:\/\/fefac.cat\/empresarial\/comunicat-oficial-fefac-cas-ima-contigo\/"},"author":{"name":"lclavijo@afb.cat","@id":"https:\/\/fefac.cat\/empresarial\/#\/schema\/person\/6ac15c94fb359972b6bfa9c752486744"},"headline":"Comunicat oficial de la FEFAC sobre el cas IMA Health","datePublished":"2025-08-05T21:29:31+00:00","dateModified":"2025-08-05T22:00:10+00:00","mainEntityOfPage":{"@id":"https:\/\/fefac.cat\/empresarial\/comunicat-oficial-fefac-cas-ima-contigo\/"},"wordCount":624,"commentCount":4,"image":{"@id":"https:\/\/fefac.cat\/empresarial\/comunicat-oficial-fefac-cas-ima-contigo\/#primaryimage"},"thumbnailUrl":"https:\/\/fefac.cat\/empresarial\/wp-content\/uploads\/2020\/06\/logo-fefac-notis.jpg","keywords":["Departament de Salut","IMA Contigo"],"articleSection":["Actualitat","Notes de premsa","Empresarials","FEFAC","AFB","AFET","AFELL","AGFE","FEFAC Actua","Reflexions de Junta"],"inLanguage":"ca","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/fefac.cat\/empresarial\/comunicat-oficial-fefac-cas-ima-contigo\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/fefac.cat\/empresarial\/comunicat-oficial-fefac-cas-ima-contigo\/","url":"https:\/\/fefac.cat\/empresarial\/comunicat-oficial-fefac-cas-ima-contigo\/","name":"Comunicat oficial de la FEFAC sobre el cas IMA Health - FEFAC","isPartOf":{"@id":"https:\/\/fefac.cat\/empresarial\/#website"},"primaryImageOfPage":{"@id":"https:\/\/fefac.cat\/empresarial\/comunicat-oficial-fefac-cas-ima-contigo\/#primaryimage"},"image":{"@id":"https:\/\/fefac.cat\/empresarial\/comunicat-oficial-fefac-cas-ima-contigo\/#primaryimage"},"thumbnailUrl":"https:\/\/fefac.cat\/empresarial\/wp-content\/uploads\/2020\/06\/logo-fefac-notis.jpg","datePublished":"2025-08-05T21:29:31+00:00","dateModified":"2025-08-05T22:00:10+00:00","author":{"@id":"https:\/\/fefac.cat\/empresarial\/#\/schema\/person\/6ac15c94fb359972b6bfa9c752486744"},"description":"Davant les informacions publicades recentment en diversos mitjans de comunicaci\u00f3, i en particular, l\u2019article de La Vanguardia titulat \u201cIMA Health contra el Goliat farmac\u00e8utic\u201d (4 d\u2019agost de 2025), la Federaci\u00f3 d\u2019Associacions de Farm\u00e0cies de Catalunya (FEFAC) vol fer les seg\u00fcents manifestacions.","breadcrumb":{"@id":"https:\/\/fefac.cat\/empresarial\/comunicat-oficial-fefac-cas-ima-contigo\/#breadcrumb"},"inLanguage":"ca","potentialAction":[{"@type":"ReadAction","target":["https:\/\/fefac.cat\/empresarial\/comunicat-oficial-fefac-cas-ima-contigo\/"]}]},{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/fefac.cat\/empresarial\/comunicat-oficial-fefac-cas-ima-contigo\/#primaryimage","url":"https:\/\/fefac.cat\/empresarial\/wp-content\/uploads\/2020\/06\/logo-fefac-notis.jpg","contentUrl":"https:\/\/fefac.cat\/empresarial\/wp-content\/uploads\/2020\/06\/logo-fefac-notis.jpg","width":230,"height":160},{"@type":"BreadcrumbList","@id":"https:\/\/fefac.cat\/empresarial\/comunicat-oficial-fefac-cas-ima-contigo\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/fefac.cat\/empresarial\/"},{"@type":"ListItem","position":2,"name":"Comunicat oficial de la FEFAC sobre el cas IMA Health"}]},{"@type":"WebSite","@id":"https:\/\/fefac.cat\/empresarial\/#website","url":"https:\/\/fefac.cat\/empresarial\/","name":"FEFAC","description":"Federaci\u00f3 d&#039;Associacions de Farm\u00e0cies de Catalunya","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/fefac.cat\/empresarial\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ca"},{"@type":"Person","@id":"https:\/\/fefac.cat\/empresarial\/#\/schema\/person\/6ac15c94fb359972b6bfa9c752486744","name":"lclavijo@afb.cat","url":"https:\/\/fefac.cat\/empresarial\/author\/laura-2\/"}]}},"_links":{"self":[{"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/posts\/241020","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/users\/2313"}],"replies":[{"embeddable":true,"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/comments?post=241020"}],"version-history":[{"count":3,"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/posts\/241020\/revisions"}],"predecessor-version":[{"id":241024,"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/posts\/241020\/revisions\/241024"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/media\/224377"}],"wp:attachment":[{"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/media?parent=241020"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/categories?post=241020"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/tags?post=241020"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}